Doctor-founded anti-aging platform Filiidei raises seed round from CNT Tech
What's the deal? FiliideiDealroom has a profile for this one. Try Dealroom →, a South Korean anti-aging and digital healthcare startup, has raised a seed round from accelerator CNT TechDealroom has a profile for this one. Try Dealroom →, announced on August 25. The company is led by chief executive officer Kwon Jun-beom, a former rehabilitation medicine specialist at Yonsei University's Severance Hospital.
What's the endgame? Filiidei uses AI multimodal measurement — via smartphone cameras and microphones — to analyse users' health and pair them with premium supplements and an IoT dispenser service. It runs a triple-revenue model spanning software, direct-to-consumer sales, and hardware.
What's it selling? Its direct-to-consumer lineup includes the anti-aging formula "Dr. NMN 300," cognitive supplement "Dr. Phosphatidylserine Ginkgo," and energy booster "Morning Booster," all designed by specialists. The brand builds on a medical YouTube channel with 100,000 subscribers.
Why now? Filiidei has been expanding ties with offline networks, including rehabilitation and nursing hospitals and franchise pharmacies. It combines healthcare with physical spaces and experiences to embed anti-aging into daily routines.
What's the money for? The company plans to upgrade its app platform, strengthen its supplement lineup and quality, expand marketing, and build a base for B2B and global expansion. It targets Japan and Southeast Asia over the long term.
The signal: The round reflects investor appetite for combining medical expertise with AI-driven personalisation, as founders position K-healthcare for wellness markets beyond Korea.
Read more: wowtale.net
Image credit: Generated with Gemini
